![]() | Only 14 pages are availabe for public view |
Abstract addition GADA positive patients were significantly younger than negative patients, age (20.9 ± 2.5 years vs 26.4 ± 3.5 years respectively) (P <0.001). Conclusion: About 8% of phenotypically type 2 diabetic youth had GADA positive antibodies which did not confer impact on c peptide level or glycemic control, yet type 1 diabetics who were GADA negative had a better glycemic control. |